The global bromelain market is estimated to exceed US$ 45.09 million in 2023 to US$ 90.15 million by 2032, growing at a compound annual growth rate (CAGR) of 8% during the forecast period from 2024 to 2032.
Bromelain, a type of protein-digesting enzyme, is derived from the pineapple fruit or stem through commercial means. There are distinct preparation methods for fruit and stem bromelain, resulting in varying enzymatic compositions. The term "bromelain" commonly refers to "stem bromelain," which is a blend of different thiol endopeptidases and additional components such as phosphatase, glucosidase, peroxidase, cellulase, escharase, and various protease inhibitors. Importantly, bromelain is effectively absorbed by the body without losing its proteolytic activity and generally does not lead to significant side effects.
Rising Prevalence of Chronic Diseases
A shift in lifestyle and dietary habits can lead to an increased risk of various chronic diseases, including diabetes, hypertension, stroke, respiratory diseases, oral diseases, obesity, arthritis, and cancer. This contributes to a growing burden of chronic illnesses globally.
According to the World Health Organization (WHO), approximately 49% of the global burden of disease and 61% of all deaths are attributed to chronic diseases. This proportion is projected to rise to 70% by 2030. Furthermore, emerging economies are expected to experience a significant increase in chronic diseases due to rapid population growth.
The rising prevalence of chronic diseases is influenced by factors such as the aging population. Bromelain, an effective health supplement, is utilized in the management of various health issues, including digestive problems, osteoarthritis, and sinusitis. Its impact on pain mediators like bradykinin contributes to its analgesic properties, as evidenced by a clinical study demonstrating its success in reducing inflammation and soft tissue swelling in arthritis patients.
This trend is expected to increase the use of medical enzymes, including bromelain, for the treatment and diagnosis of chronic diseases, thereby further propelling the global bromelain market.
Side Effects of Bromelin
Excessive intake of bromelain may lead to mild side effects such as diarrhea, vomiting, nausea, and heavier menstrual bleeding. Additionally, there is insufficient strong evidence regarding its safety during pregnancy or breastfeeding.
Topical application of bromelain typically poses no issues, but in some cases, it may trigger allergies. Specific contraindications related to the concurrent use of bromelain with anticoagulant drugs or antiplatelets can lead to excessive bruising and bleeding, thereby limiting the adoption of bromelain.
Coupling bromelain with antibiotics like tetracycline or amoxicillin could also result in side effects. Furthermore, its use alongside antiplatelet and anticoagulant drugs can be counterproductive, causing excessive bruising and bleeding, thereby restraining the utilization of bromelain and subsequently impeding its market growth.
Rising Consumption of Plant-Based Products
The rising desire for natural and plant-derived products stands out as a primary catalyst for the growth of the bromelain market. Health-conscious consumers are seeking natural alternatives to conventional medications, fueling the demand for natural ingredients such as bromelain.
Enzymes obtained from natural sources, whether plant- or animal-derived, often possess a distinctive blend of enzymatic activities that define their function, specificity, and applicability in diverse industrial uses. Bromelain preparations, comprising enzymes extracted from pineapples, exhibit unique sulfhydryl proteolytic activities that are challenging to replicate with microbial or recombinant enzymes.
Given its natural and plant-based nature, bromelain is increasingly finding applications in various health supplements and medications, attributed to its anti-inflammatory and digestive properties. This shift toward natural and plant-based products is projected to sustain the demand for bromelain in the market.
By Source
Stem Bromelain has emerged as the frontrunner in the global market, primarily due to its heightened enzymatic activity and wider range of applications. Stem Bromelain, sourced from the pineapple stem, commands the largest market share, attributed to its superior enzymatic activity in comparison to fruit Bromelain, rendering it more effective across diverse applications.
The extensive utilization of Stem Bromelain in the healthcare sector, leveraging its anti-inflammatory and digestive advantages, is noteworthy. Additionally, it is widely favored in the food and beverage industry for its role in meat tenderization and protein hydrolysis. The demand for Stem Bromelain is further propelled by its effectiveness in wound healing and incorporation into dietary supplements. These combined factors propel the expansion of Stem Bromelain in the market, consolidating its leading position.
By Application
The food and beverage industry stands as the primary application segment for Bromelain, mainly attributed to its extensive utilization in meat tenderization. The ability of Bromelain to break down protein structures proves invaluable for enhancing meat texture and decreasing cooking durations, offering significant advantages to both commercial food processors and home cooks.
Several methods have been employed for the extraction and purification of bromelain, including filtration, membrane filtration, INT filtration, precipitation, aqueous two-phase system, ion exchange chromatography, and more. This enzyme finds extensive utilization in the food industry for purposes, such as meat tenderization, baking, cheese processing, seafood processing, and other applications.
Moreover, Bromelain finds application in brewing processes and serves as a dietary supplement in various food products, further propelling its demand within this segment. The increasing consumer preference for high-quality and easily digestible food products contributes to the heightened usage of Bromelain in the food and beverage industry, solidifying its leading position.
Regional Analysis
The Asia-Pacific region is anticipated to demonstrate the most rapid Compound Annual Growth Rate (CAGR) of the market during the forecast period. This acceleration is primarily fueled by the burgeoning baking and confectionery sectors, driven by the escalating demand for bromelain within the food and beverage industry. The utilization of bromelain in beer production and as a meat tenderizer is fostering market expansion within the region. Notably, India has emerged as the swiftest growing bromelain market in the Asia-Pacific region, while China commands the largest market share.
The Asia-Pacific region stands as the primary global producer of pineapples, providing an ideal environment for pineapple cultivation due to its optimal land and temperature conditions. This has led to the establishment of major bromelain manufacturing facilities within the region. The presence of tropical plantations yields abundant high-quality pineapples, ensuring a consistent supply of raw materials for production.
Furthermore, the region's burgeoning demand for the enzyme is attributed to the presence of key market players, escalating disposable incomes, evolving lifestyles, and heightened awareness of healthy dietary practices in response to increasing incidences of health disorders.
This comprehensive overview underscores the promising growth prospects for the Asia-Pacific bromelain market, propelled by the escalating demand for bromelain across diverse industries and the region's conducive conditions for pineapple cultivation, serving as the primary raw material for bromelain production.
Key Companies Profiled in the Global Bromelain Market
Market Segmentation Outline
By Source
By Application
By Region
1 INTRODUCTION OF GLOBAL BROMELAIN MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: BROMELAIN MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL BROMELAIN MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL BROMELAIN MARKET, BY SOURCE
5.1 OVERVIEW
5.2 STEM
5.3 FRUITS
6 GLOBAL BROMELAIN MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 HEALTHCARE & PHARMACEUTICALS
6.3 DIETARY SUPPLEMENTS
6.4 PERSONAL CARE & COSMETICS
6.5 FOOD & BEVERAGES
6.6 OTHERS
7 GLOBAL BROMELAIN MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL BROMELAIN MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 ADVANCED ENZYME TECHNOLOGIES
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 CHANGSHA NATUREWAY CO., LTD.
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 CREATIVE ENZYMES
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 ENZYBEL INTERNATIONAL SA
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 ENZYME DEVELOPMENT CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 FOOD STATE COMPANY
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 FOODING GROUP LIMITED
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 GREAT FOOD GROUP OF COMPANIES ENZYME TECHNOLOGY LTD.
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 GUANGXI NANNING JAVELY BIOLOGICAL PRODUCTS CO., LTD.
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.10 HONG MAO BIOCHEMICALS CO., LTD.
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 KRISHNA ENZYTECH PVT. LTD
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 NANNING PANGBO BIOLOGICAL ENGINEERING CO., LTD.
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 NUTRITECH
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
著作権 ©2022 無断複写・転載を禁じます